Stratos Wealth Partners, Ltd. Indaptus Therapeutics, Inc. Transaction History

Stratos Wealth Partners, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$1.94 - $4.02 $2.25 Million - $4.67 Million	-1,161,524 Reduced 97.74%	26,832 $70,000
Q1 2022 Apr 26, 2022	SELL	$3.19 - $6.17 $638,000 - $1.23 Million	-200,000 Reduced 14.41%	1,188,356 $4.75 Million
Q4 2021 Jan 14, 2022	BUY	$5.21 - $7.93 $7.23 Million - $11 Million	1,388,356 New	1,388,356 $7.91 Million

600K

Ticker INDP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,258,600
Market Cap $9.66M
Description
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.